Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This work was supported by the Natural Science Foundation of Hebei Province (H2014206117), China.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Noris P, Balduini CL. Inherited thrombocytopenias in the era of personalized medicine. Haematologica 2015;100:145–8.10.3324/haematol.2014.122549Search in Google Scholar PubMed PubMed Central
2. Pecci A, Klersy C, Gresele P, Lee KJ, De Rocco D, Bozzi V, et al. MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. Hum Mutat 2014;35:236–47.10.1002/humu.22476Search in Google Scholar PubMed PubMed Central
3. Saposnik B, Binard S, Fenneteau O, Nurden A, Nurden P, Hurtaud-Roux MF, et al. Mutation spectrum and genotype-phenotype correlations in a large French cohort of MYH9-related disorders. Mol Genet Genomic Med 2014;2:297–312.10.1002/mgg3.68Search in Google Scholar PubMed PubMed Central
4. Franke JD, Dong F, Rickoll WL, Kelley MJ, Kiehart DP. Rod mutations associated with MYH9-related disorders disrupt nonmuscle myosin-IIA assembly. Blood 2005;105:161–9.10.1182/blood-2004-06-2067Search in Google Scholar PubMed
5. Heath KE, Campos-Barros A, Toren A, Rozenfeld-Granot G, Carlsson LE, Savige J, et al. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet 2001;69:1033–45.10.1086/324267Search in Google Scholar PubMed PubMed Central
6. Kunishima S, Kojima T, Matsushita T, Tanaka T, Tsurusawa M, Furukawa Y, et al. Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome). Blood 2001;97:1147–9.10.1182/blood.V97.4.1147Search in Google Scholar
7. Oh T, Jung Seo H, Taek Lee K, Jo Kim H, Jun Kim H, Lee JH, et al. MYH9 nephropathy. Kidney Res Clin Pract 2015;34:53–6.10.1016/j.krcp.2014.09.003Search in Google Scholar PubMed PubMed Central
8. Wasano K, Matsunaga T, Ogawa K, Kunishima S. Late onset and high-frequency dominant hearing loss in a family with MYH9 disorder. Eur Arch Otorhinolaryngol 2016;273:3547–52.10.1007/s00405-016-3954-0Search in Google Scholar PubMed
9. Savasi V, Laoreti A, Elli M, Brambilla T, Federici A, Cetin I, et al. First report of reproductive assistance in a woman affected by May-Hegglin anomaly. Arch Gynecol Obstet 2012;285:879–82.10.1007/s00404-011-2117-1Search in Google Scholar PubMed
10. Yamashita Y, Matsuura R, Kunishima S, Oikawa Y, Ariizumi H, Hamada S, et al. Perinatal management for a pregnant woman with an MYH9 disorder. Case Rep Obstet Gynecol 2016;2016:6730174.Search in Google Scholar
©2018 Walter de Gruyter GmbH, Berlin/Boston
